Engineering of Chimeric Antigen Receptor T Cells with Integrin αEβ7 Results in Augmented Therapeutic Efficacy Against E-Cadherin Positive Tumor | Zendy

AI Assistant Blog Pricing

Open Access

Engineering of Chimeric Antigen Receptor T Cells with Integrin αEβ7 Results in Augmented Therapeutic Efficacy Against E-Cadherin Positive Tumor

Author(s) -

Hongxing Sun,

Shan He,

Lijun Meng,

Ying Wang,

Hanghang Zhang,

Yongnian Liu,

Jian Wang,

Min Tao,

Stefan K. Barta,

Essel Dulaimi,

Henry C. Fung,

JeanPierre J. Issa,

Leizhen Zheng,

Yi Zhang

Publication year - 2018

Publication title -

ssrn electronic journal

Language(s) - English

Resource type - Journals

ISSN - 1556-5068

DOI - 10.2139/ssrn.3294754

Subject(s) - chimeric antigen receptor , cadherin , antigen , cancer research , integrin , receptor , medicine , chemistry , immunology , cancer , immunotherapy , cell , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.